ImmunityBio Reports Sales Momentum & Unit Growth Since Permanent J-code Issuance (J9028) in January 2025 and Financial Results for Year End 2024 Business Wire Mon, Mar 3, 2025, 7:30 AM 18 min read ...

Robust franchise unit growth in the quarter fueled the outperformance, although a waning consumer appetite for restaurant spending tempers our 2025 outlook for comparable sales growth. Overall ...

It has already gained strong momentum in the automotive world ... BlackBerry’s QNX business, formed by rebranding its IoT unit, is gaining from strength in the automotive segment, particularly ...

ImmunityBio has seen increased sales momentum supporting a trend of increases month-over-month as well as quarter-over-quarter, with February unit sales volume increasing 67% over January ...

Cytokine fusion proteins, such as ANKTIVA, represent a novel class of biologics that improve immune responses by enhancing the therapeutic potential of cytokines and promoting lymphocyte ...